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Neurofibromatosis type 1 (NF1) is a clinically heterogeneous cancer predisposition 
syndrome caused by a germline mutation in one of the two alleles of the NF1 gene. Low 
grade gliomas (LGGs), particularly in the optic pathway, are common in patients with NF1 
(15-20%). These tumors arise when the remaining allele is somatically inactivated in glial 
progenitor cells. Nf1 genetically-engineered mouse (GEM) models have been employed 
to study NF1-associated LGGs; however, there are still a limited number of therapeutic 
targets available. This lack of clinical translation could reflect species-specific differences 
between rodents and humans or the use of “knockout” mutations in the mouse models, 
whereas patients with NF1 harbor a diverse number of germline NF1 gene mutations. To 
study the importance of the germline mutation to LGG development and progression 
in human cells, the Gutmann Laboratory has created a collection of human induced 
pluripotent stem cells (hiPSCs) with NF1 patient mutations and hiPSC-derived cerebral 
organoids. Using this resource, we have generated mixed cerebral organoids comprised 
of hiPSCs homozygous for patient-specific NF1 mutations and hiPSCs heterozygous for 
distinct NF1 mutations spanning the NF1 gene. Our preliminary results demonstrate 
that these mixed organoid cultures exhibit histological characteristics of NF1-LGGs. 
Future experiments employing this model will evaluate the differential effects of NF1 
mutations on LGG formation and growth.
